Median Technologies: Financial Communications Schedule for the First Half of 2025
15 January 2025 - 3:45AM
Business Wire
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme
eligible), announces the publication date for its 2024 results:
Publication
Date
2024 results
April 29, 2025*
*Distribution after the close of trading
About Median Technologies: Pioneering innovative imaging
services and Software as Medical Devices, Median Technologies
harnesses cutting-edge AI to enhance the accuracy of early cancer
diagnoses and treatments. Median's offerings include iCRO, which
provides medical image analysis and management in oncology trials,
and eyonis™, an AI/ML tech-based suite of software as medical
devices (SaMD). Median empowers biopharmaceutical entities and
clinicians to advance patient care and expedite the development of
novel therapies. The French-based company, with a presence in the
U.S. and China, trades on the Euronext Growth market (ISIN:
FR0011049824, ticker: ALMDT). Median is also eligible for the
French SME equity savings plan scheme (PEA-PME). For more
information, visit www.mediantechnologies.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250114644784/en/
MEDIAN TECHNOLOGIES Emmanuelle Leygues VP, Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Investors Ghislaine Gasparetto SEITOSEI ACTIFIN
+33 6 21 10 49 24 ghislaine.gasparetto@seitosei-actifin.com
U.S. media & investors Chris Maggos COHESION
BUREAU +41 79 367 6254 chris.maggos@cohesionbureau.com
Press Caroline Carmagnol ALIZE RP +33 6 64 18 99
59 median@alizerp.com
Median Technologies (EU:ALMDT)
Historical Stock Chart
From Dec 2024 to Jan 2025
Median Technologies (EU:ALMDT)
Historical Stock Chart
From Jan 2024 to Jan 2025
